Table of Contents
Egyptian healthcare provider Integrated Diagnostics Holdings (IDH) delivered solid financial results in 2023, exceeding revenue expectations.
Led by Egyptian businesswoman Hend El-Sherbini, the company reported consolidated revenue of EGP4.1 billion ($84.53 million), a 13.73-percent increase year-over-year from EGP3.61 billion ($74.25 million). This growth is particularly impressive considering that 19 percent of IDH’s 2022 revenue stemmed from COVID-19 testing.
Resilience in core markets drives growth
IDH’s core markets of Egypt and Jordan demonstrated strong performance, highlighting the company’s strategic progress. While net profit for 2023 dipped 11 percent year-over-year to EGP 468 million ($9.65 million), resulting in an 11-percent net-profit margin, the company points to its robust conventional business growth as a key driver.
Its conventional business, excluding COVID-19 testing, surged 42 percent in 2023, surpassing pre-pandemic revenue levels by 89 percent. This segment’s revenue reached EGP3.67 billion ($75.63 million) in 2023, compared to EGP2.179 billion ($44.93 million) in 2019.
IDH CEO applauds resilience, growth
Commenting on the results, CEO Hend El-Sherbini emphasized IDH’s ability to navigate a challenging environment and deliver strong growth. “The company experienced significant growth and profitability with 42-percent growth in the conventional business, representing 89 percent above pre-pandemic revenues of EGP 2.179 billion ($44.93 million) in 2019.” she stated, highlighting the 42-percent conventional business expansion.
El-Sherbini added that IDH’s core markets of Egypt and Jordan displayed strong growth, indicating further potential. She expressed confidence in the company’s long-term growth strategies, particularly its focus on expanding the conventional business and navigating the post-pandemic landscape.
Leading diagnostic services provider in MENA
Headquartered in Saint Helier, Jersey, IDH is a prominent consumer healthcare group within the Middle East and Africa (MEA) region. The company boasts a network of 483 labs across four countries (Egypt, Jordan, Sudan, and Nigeria), solidifying its position as Egypt’s largest diagnostic service provider.
El-Sherbini, a leading businesswoman in Egypt, holds a significant 26.71-percent stake (160,250,305 ordinary shares) in IDH and has been instrumental in the company’s growth and transformation.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now
